11 Lupus Clinical Trials in Columbus, OH (2026)

Q: How do I join a clinical trial in Columbus?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you.

Recruiting Lupus Studies in Columbus

NCT04712656Recruiting

Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea

The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apne...

Columbus, OH1,739 participantsOhio State University

View Study Details

NCT03487185Recruiting

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate ...

Columbus, OHNA1,500 participantsThe George Washington University Biostatistics Center

View Study Details

NCT07213908Recruiting

Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth

The goal of this clinical trial is to conduct a comparative effectiveness trial that will evaluate two school-based interventions to improve adolescent sleep health: the standard Sleep Health Educatio...

Columbus, OHNA1,320 participantsChildren's Hospital Los Angeles

View Study Details

NCT06189755Recruiting

MicroRNAs as Biomarkers for Obstructive Sleep Apnea

Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop an...

Columbus, OH500 participantsUniversity of Pennsylvania

View Study Details

NCT06527872Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple countries of interest. Thi...

Columbus, OH300 participantsGlaxoSmithKline

View Study Details

NCT05742360Recruiting

Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

The primary objective of this study is to determine the longer-term (6 months) effect of CPAP therapy on change in 24-hour mean blood pressure (24hMBP) in OSA subjects with the excessively sleepy symp...

Columbus, OH227 participantsOhio State University

View Study Details

NCT06576271Recruiting

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active SLE (Part B), healthy pa...

Columbus, OHPHASE1142 participantsGlaxoSmithKline

View Study Details

NCT06075914Recruiting

Ketone Conferred Resiliency Against Sleep Restriction With Nutritional Intervention.

Sleep deprivation is a major problem in military populations. Some major consequences of sleep loss are inability to concentrate, poor work efficiency, and increase in errors during daily tasks. Ketog...

Columbus, OHNA60 participantsOhio State University

View Study Details

NCT06556693Recruiting

Janus II Feasibility

The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety....

Columbus, OHNA40 participantsZoll Medical Corporation

View Study Details

NCT07225387Recruiting

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

This is a Phase IV, open-label, randomized trial to determine whether the combination of Belimumab (BEL) and Voclosporin (VCS), plus background therapy with Mycophenolate Mofetil (MMF), improves the p...

Columbus, OHPHASE430 participantsNephroNet, Inc.

View Study Details

NCT06340750Recruiting

BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus

This phase 1 study seeks to examine the safety and recommended phase 2 dose (RP2D) of BAFF-ligand CAR-T cells (LMY-920) in adult patients with refractory systemic lupus erythematosus (SLE). It is hypo...

Columbus, OHPHASE118 participantsLuminary Therapeutics

View Study Details

About Lupus Clinical Trials in Columbus

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 11 lupus clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 5,876 participants. Research is being sponsored by Ohio State University, The George Washington University Biostatistics Center, Children's Hospital Los Angeles and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in Columbus — FAQ

Are there lupus clinical trials in Columbus?

Yes, there are 11 lupus clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbus?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.

Are clinical trials in Columbus free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.

What lupus treatments are being tested?

The 11 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated July 17, 2026 from ClinicalTrials.gov